Quantifying prion disease penetrance using large population control cohorts

Eric Vallabh Minikel, Sonia M. Vallabh, Monkol Lek, Karol Estrada, Kaitlin E. Samocha, J. Fah Sathirapongsasuti, Cory Y. McLean, Joyce Y. Tung, Linda P C Yu, Pierluigi Gambetti, Janis Blevins, Shulin Zhang, Yvonne Cohen, Wei Chen, Masahito Yamada, Tsuyoshi Hamaguchi, Nobuo Sanjo, Hidehiro Mizusawa, Yosikazu Nakamura, Tetsuyuki Kitamoto & 43 others Steven J. Collins, Alison Boyd, Robert G. Will, Richard Knight, Claudia Ponto, Inga Zerr, Theo F J Kraus, Sabina Eigenbrod, Armin Giese, Miguel Calero, Jesús De Pedro-Cuesta, Stéphane Haïk, Jean Louis Laplanche, Elodie Bouaziz-Amar, Jean Philippe Brandel, Sabina Capellari, Piero Parchi, Anna Poleggi, Anna Ladogana, Anne H. O'Donnell-Luria, Konrad J. Karczewski, Jamie L. Marshall, Michael Boehnke, Markku Laakso, Karen L. Mohlke, Anna Kähler, Kimberly Chambert, Steven McCarroll, Patrick F. Sullivan, Christina M. Hultman, Shaun M. Purcell, Pamela Sklar, Sven J. Van Der Lee, Annemieke Rozemuller, Casper Jansen, Albert Hofman, Robert Kraaij, Jeroen G J Van Rooij, M. Arfan Ikram, André G. Uitterlinden, Cornelia M. Van Duijn, Mark J. Daly, Daniel G. MacArthur

Research output: Contribution to journalArticle

112 Citations (Scopus)

Abstract

More than 100,000 genetic variants are reported to cause Mendelian disease in humans, but the penetrance-the probability that a carrier of the purported disease-causing genotype will indeed develop the disease-is generally unknown. We assess the impact of variants in the prion protein gene (PRNP) on the risk of prion disease by analyzing 16,025 prion disease cases, 60,706 population control exomes, and 531,575 individuals genotyped by 23andMe Inc. We show that missense variants in PRNP previously reported to be pathogenic are at least 30 times more common in the population than expected on the basis of genetic prion disease prevalence. Although some of this excess can be attributed to benign variants falsely assigned as pathogenic, other variants have genuine effects on disease susceptibility but confer lifetime risks ranging from

Original languageEnglish
Article number322ra9
Pages (from-to)1-12
JournalScience Translational Medicine
Volume8
Issue number322
DOIs
Publication statusPublished - Jan 20 2016

Fingerprint

Prion Diseases
Population Control
Penetrance
Exome
Inborn Genetic Diseases
Disease Susceptibility
Genes
Genotype
Population
Prion Proteins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Minikel, E. V., Vallabh, S. M., Lek, M., Estrada, K., Samocha, K. E., Sathirapongsasuti, J. F., ... MacArthur, D. G. (2016). Quantifying prion disease penetrance using large population control cohorts. Science Translational Medicine, 8(322), 1-12. [322ra9]. https://doi.org/10.1126/scitranslmed.aad5169

Quantifying prion disease penetrance using large population control cohorts. / Minikel, Eric Vallabh; Vallabh, Sonia M.; Lek, Monkol; Estrada, Karol; Samocha, Kaitlin E.; Sathirapongsasuti, J. Fah; McLean, Cory Y.; Tung, Joyce Y.; Yu, Linda P C; Gambetti, Pierluigi; Blevins, Janis; Zhang, Shulin; Cohen, Yvonne; Chen, Wei; Yamada, Masahito; Hamaguchi, Tsuyoshi; Sanjo, Nobuo; Mizusawa, Hidehiro; Nakamura, Yosikazu; Kitamoto, Tetsuyuki; Collins, Steven J.; Boyd, Alison; Will, Robert G.; Knight, Richard; Ponto, Claudia; Zerr, Inga; Kraus, Theo F J; Eigenbrod, Sabina; Giese, Armin; Calero, Miguel; De Pedro-Cuesta, Jesús; Haïk, Stéphane; Laplanche, Jean Louis; Bouaziz-Amar, Elodie; Brandel, Jean Philippe; Capellari, Sabina; Parchi, Piero; Poleggi, Anna; Ladogana, Anna; O'Donnell-Luria, Anne H.; Karczewski, Konrad J.; Marshall, Jamie L.; Boehnke, Michael; Laakso, Markku; Mohlke, Karen L.; Kähler, Anna; Chambert, Kimberly; McCarroll, Steven; Sullivan, Patrick F.; Hultman, Christina M.; Purcell, Shaun M.; Sklar, Pamela; Van Der Lee, Sven J.; Rozemuller, Annemieke; Jansen, Casper; Hofman, Albert; Kraaij, Robert; Van Rooij, Jeroen G J; Ikram, M. Arfan; Uitterlinden, André G.; Van Duijn, Cornelia M.; Daly, Mark J.; MacArthur, Daniel G.

In: Science Translational Medicine, Vol. 8, No. 322, 322ra9, 20.01.2016, p. 1-12.

Research output: Contribution to journalArticle

Minikel, EV, Vallabh, SM, Lek, M, Estrada, K, Samocha, KE, Sathirapongsasuti, JF, McLean, CY, Tung, JY, Yu, LPC, Gambetti, P, Blevins, J, Zhang, S, Cohen, Y, Chen, W, Yamada, M, Hamaguchi, T, Sanjo, N, Mizusawa, H, Nakamura, Y, Kitamoto, T, Collins, SJ, Boyd, A, Will, RG, Knight, R, Ponto, C, Zerr, I, Kraus, TFJ, Eigenbrod, S, Giese, A, Calero, M, De Pedro-Cuesta, J, Haïk, S, Laplanche, JL, Bouaziz-Amar, E, Brandel, JP, Capellari, S, Parchi, P, Poleggi, A, Ladogana, A, O'Donnell-Luria, AH, Karczewski, KJ, Marshall, JL, Boehnke, M, Laakso, M, Mohlke, KL, Kähler, A, Chambert, K, McCarroll, S, Sullivan, PF, Hultman, CM, Purcell, SM, Sklar, P, Van Der Lee, SJ, Rozemuller, A, Jansen, C, Hofman, A, Kraaij, R, Van Rooij, JGJ, Ikram, MA, Uitterlinden, AG, Van Duijn, CM, Daly, MJ & MacArthur, DG 2016, 'Quantifying prion disease penetrance using large population control cohorts', Science Translational Medicine, vol. 8, no. 322, 322ra9, pp. 1-12. https://doi.org/10.1126/scitranslmed.aad5169
Minikel EV, Vallabh SM, Lek M, Estrada K, Samocha KE, Sathirapongsasuti JF et al. Quantifying prion disease penetrance using large population control cohorts. Science Translational Medicine. 2016 Jan 20;8(322):1-12. 322ra9. https://doi.org/10.1126/scitranslmed.aad5169
Minikel, Eric Vallabh ; Vallabh, Sonia M. ; Lek, Monkol ; Estrada, Karol ; Samocha, Kaitlin E. ; Sathirapongsasuti, J. Fah ; McLean, Cory Y. ; Tung, Joyce Y. ; Yu, Linda P C ; Gambetti, Pierluigi ; Blevins, Janis ; Zhang, Shulin ; Cohen, Yvonne ; Chen, Wei ; Yamada, Masahito ; Hamaguchi, Tsuyoshi ; Sanjo, Nobuo ; Mizusawa, Hidehiro ; Nakamura, Yosikazu ; Kitamoto, Tetsuyuki ; Collins, Steven J. ; Boyd, Alison ; Will, Robert G. ; Knight, Richard ; Ponto, Claudia ; Zerr, Inga ; Kraus, Theo F J ; Eigenbrod, Sabina ; Giese, Armin ; Calero, Miguel ; De Pedro-Cuesta, Jesús ; Haïk, Stéphane ; Laplanche, Jean Louis ; Bouaziz-Amar, Elodie ; Brandel, Jean Philippe ; Capellari, Sabina ; Parchi, Piero ; Poleggi, Anna ; Ladogana, Anna ; O'Donnell-Luria, Anne H. ; Karczewski, Konrad J. ; Marshall, Jamie L. ; Boehnke, Michael ; Laakso, Markku ; Mohlke, Karen L. ; Kähler, Anna ; Chambert, Kimberly ; McCarroll, Steven ; Sullivan, Patrick F. ; Hultman, Christina M. ; Purcell, Shaun M. ; Sklar, Pamela ; Van Der Lee, Sven J. ; Rozemuller, Annemieke ; Jansen, Casper ; Hofman, Albert ; Kraaij, Robert ; Van Rooij, Jeroen G J ; Ikram, M. Arfan ; Uitterlinden, André G. ; Van Duijn, Cornelia M. ; Daly, Mark J. ; MacArthur, Daniel G. / Quantifying prion disease penetrance using large population control cohorts. In: Science Translational Medicine. 2016 ; Vol. 8, No. 322. pp. 1-12.
@article{74fe4370294f49cba7f97d55d68482bd,
title = "Quantifying prion disease penetrance using large population control cohorts",
abstract = "More than 100,000 genetic variants are reported to cause Mendelian disease in humans, but the penetrance-the probability that a carrier of the purported disease-causing genotype will indeed develop the disease-is generally unknown. We assess the impact of variants in the prion protein gene (PRNP) on the risk of prion disease by analyzing 16,025 prion disease cases, 60,706 population control exomes, and 531,575 individuals genotyped by 23andMe Inc. We show that missense variants in PRNP previously reported to be pathogenic are at least 30 times more common in the population than expected on the basis of genetic prion disease prevalence. Although some of this excess can be attributed to benign variants falsely assigned as pathogenic, other variants have genuine effects on disease susceptibility but confer lifetime risks ranging from",
author = "Minikel, {Eric Vallabh} and Vallabh, {Sonia M.} and Monkol Lek and Karol Estrada and Samocha, {Kaitlin E.} and Sathirapongsasuti, {J. Fah} and McLean, {Cory Y.} and Tung, {Joyce Y.} and Yu, {Linda P C} and Pierluigi Gambetti and Janis Blevins and Shulin Zhang and Yvonne Cohen and Wei Chen and Masahito Yamada and Tsuyoshi Hamaguchi and Nobuo Sanjo and Hidehiro Mizusawa and Yosikazu Nakamura and Tetsuyuki Kitamoto and Collins, {Steven J.} and Alison Boyd and Will, {Robert G.} and Richard Knight and Claudia Ponto and Inga Zerr and Kraus, {Theo F J} and Sabina Eigenbrod and Armin Giese and Miguel Calero and {De Pedro-Cuesta}, Jes{\'u}s and St{\'e}phane Ha{\"i}k and Laplanche, {Jean Louis} and Elodie Bouaziz-Amar and Brandel, {Jean Philippe} and Sabina Capellari and Piero Parchi and Anna Poleggi and Anna Ladogana and O'Donnell-Luria, {Anne H.} and Karczewski, {Konrad J.} and Marshall, {Jamie L.} and Michael Boehnke and Markku Laakso and Mohlke, {Karen L.} and Anna K{\"a}hler and Kimberly Chambert and Steven McCarroll and Sullivan, {Patrick F.} and Hultman, {Christina M.} and Purcell, {Shaun M.} and Pamela Sklar and {Van Der Lee}, {Sven J.} and Annemieke Rozemuller and Casper Jansen and Albert Hofman and Robert Kraaij and {Van Rooij}, {Jeroen G J} and Ikram, {M. Arfan} and Uitterlinden, {Andr{\'e} G.} and {Van Duijn}, {Cornelia M.} and Daly, {Mark J.} and MacArthur, {Daniel G.}",
note = "Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Universit{\`a} di Bologna (Capellari Sabina, Parchi Piero)",
year = "2016",
month = "1",
day = "20",
doi = "10.1126/scitranslmed.aad5169",
language = "English",
volume = "8",
pages = "1--12",
journal = "Science Translational Medicine",
issn = "1946-6234",
publisher = "American Association for the Advancement of Science",
number = "322",

}

TY - JOUR

T1 - Quantifying prion disease penetrance using large population control cohorts

AU - Minikel, Eric Vallabh

AU - Vallabh, Sonia M.

AU - Lek, Monkol

AU - Estrada, Karol

AU - Samocha, Kaitlin E.

AU - Sathirapongsasuti, J. Fah

AU - McLean, Cory Y.

AU - Tung, Joyce Y.

AU - Yu, Linda P C

AU - Gambetti, Pierluigi

AU - Blevins, Janis

AU - Zhang, Shulin

AU - Cohen, Yvonne

AU - Chen, Wei

AU - Yamada, Masahito

AU - Hamaguchi, Tsuyoshi

AU - Sanjo, Nobuo

AU - Mizusawa, Hidehiro

AU - Nakamura, Yosikazu

AU - Kitamoto, Tetsuyuki

AU - Collins, Steven J.

AU - Boyd, Alison

AU - Will, Robert G.

AU - Knight, Richard

AU - Ponto, Claudia

AU - Zerr, Inga

AU - Kraus, Theo F J

AU - Eigenbrod, Sabina

AU - Giese, Armin

AU - Calero, Miguel

AU - De Pedro-Cuesta, Jesús

AU - Haïk, Stéphane

AU - Laplanche, Jean Louis

AU - Bouaziz-Amar, Elodie

AU - Brandel, Jean Philippe

AU - Capellari, Sabina

AU - Parchi, Piero

AU - Poleggi, Anna

AU - Ladogana, Anna

AU - O'Donnell-Luria, Anne H.

AU - Karczewski, Konrad J.

AU - Marshall, Jamie L.

AU - Boehnke, Michael

AU - Laakso, Markku

AU - Mohlke, Karen L.

AU - Kähler, Anna

AU - Chambert, Kimberly

AU - McCarroll, Steven

AU - Sullivan, Patrick F.

AU - Hultman, Christina M.

AU - Purcell, Shaun M.

AU - Sklar, Pamela

AU - Van Der Lee, Sven J.

AU - Rozemuller, Annemieke

AU - Jansen, Casper

AU - Hofman, Albert

AU - Kraaij, Robert

AU - Van Rooij, Jeroen G J

AU - Ikram, M. Arfan

AU - Uitterlinden, André G.

AU - Van Duijn, Cornelia M.

AU - Daly, Mark J.

AU - MacArthur, Daniel G.

N1 - Ricercatori distaccati presso IRCCS a seguito Convenzione esclusiva con Università di Bologna (Capellari Sabina, Parchi Piero)

PY - 2016/1/20

Y1 - 2016/1/20

N2 - More than 100,000 genetic variants are reported to cause Mendelian disease in humans, but the penetrance-the probability that a carrier of the purported disease-causing genotype will indeed develop the disease-is generally unknown. We assess the impact of variants in the prion protein gene (PRNP) on the risk of prion disease by analyzing 16,025 prion disease cases, 60,706 population control exomes, and 531,575 individuals genotyped by 23andMe Inc. We show that missense variants in PRNP previously reported to be pathogenic are at least 30 times more common in the population than expected on the basis of genetic prion disease prevalence. Although some of this excess can be attributed to benign variants falsely assigned as pathogenic, other variants have genuine effects on disease susceptibility but confer lifetime risks ranging from

AB - More than 100,000 genetic variants are reported to cause Mendelian disease in humans, but the penetrance-the probability that a carrier of the purported disease-causing genotype will indeed develop the disease-is generally unknown. We assess the impact of variants in the prion protein gene (PRNP) on the risk of prion disease by analyzing 16,025 prion disease cases, 60,706 population control exomes, and 531,575 individuals genotyped by 23andMe Inc. We show that missense variants in PRNP previously reported to be pathogenic are at least 30 times more common in the population than expected on the basis of genetic prion disease prevalence. Although some of this excess can be attributed to benign variants falsely assigned as pathogenic, other variants have genuine effects on disease susceptibility but confer lifetime risks ranging from

UR - http://www.scopus.com/inward/record.url?scp=84955582450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955582450&partnerID=8YFLogxK

U2 - 10.1126/scitranslmed.aad5169

DO - 10.1126/scitranslmed.aad5169

M3 - Article

VL - 8

SP - 1

EP - 12

JO - Science Translational Medicine

JF - Science Translational Medicine

SN - 1946-6234

IS - 322

M1 - 322ra9

ER -